Related Experiment Video
Updated: Jun 3, 2026
05:18
Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources
Published on: October 6, 2023
Cervical Cancer in Australia: A Radiation Oncology Perspective on Recent Developments, Challenges and Future
Daniel Mills1,2, Swetha Sridharan1,2, Geetha Govindarajulu1,2
1Department of Radiation Oncology, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
Journal of Medical Imaging and Radiation Oncology
|June 2, 2026
Summary
Australia
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- Cervical cancer incidence and mortality in Australia have significantly decreased over recent decades.
- The national HPV Vaccination Program and National Cervical Screening Program (NCSP) have been pivotal in this decline.
- Advances in treatment modalities have improved patient outcomes and survival rates.
Purpose of the Study:
- To review the evolution of cervical cancer care in Australia.
- To summarize current practices and clinical outcomes.
- To identify key challenges and future directions for cervical cancer elimination.
Main Methods:
- Literature review of developments in cervical cancer care in Australia.
- Analysis of population-based data and institutional series.
- Synthesis of information on vaccination, screening, surgical techniques, radiotherapy, and systemic therapies.
Main Results:
- Sustained declines in cervical cancer incidence and mortality are evident.
- Elimination as a public health problem is potentially achievable within the next decade.
- Australian research contributes significantly to global progress, with outcomes comparable to international standards.
Conclusions:
- Continued engagement among clinicians, policymakers, and stakeholders is crucial.
- Addressing challenges such as maintaining brachytherapy expertise, ensuring equitable access, and integrating new therapies is essential.
- The field is moving towards the elimination of cervical cancer as a public health concern.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...